JTC Employer Solutions Trustee’s Teva Pharmaceuticals TEVA Stock Holding History

JTC Employer Solutions Trustee’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29K	Sell	960 -2,240	-70%	-$72.1K	﹤0.01%	259
2025 Q4	$100K	Hold	3,200	–	–	0.01%	211
2025 Q3	$65K	Buy	+3,200	New	+$56.2K	0.01%	229
2023 Q4	–	Sell	-800	Closed	-$8K	–	361
2023 Q3	$8K	Hold	800	–	–	﹤0.01%	320
2023 Q2	$6K	Hold	800	–	–	﹤0.01%	337
2023 Q1	$7K	Hold	800	–	–	﹤0.01%	343
2022 Q4	$7K	Hold	800	–	–	﹤0.01%	362
2022 Q3	$6K	Hold	800	–	–	﹤0.01%	300
2022 Q2	$6K	Hold	800	–	–	﹤0.01%	276
2022 Q1	$8K	Hold	800	–	–	﹤0.01%	284
2021 Q4	$6K	Hold	800	–	–	﹤0.01%	291
2021 Q3	$8K	Hold	800	–	–	﹤0.01%	286
2021 Q2	$8K	Buy	+800	New	+$8.47K	﹤0.01%	279

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JTC Employer Solutions Trustee's TEVA Position: Q1 2026 in Review

JTC Employer Solutions Trustee reduced its Teva Pharmaceuticals (TEVA) stake by 70% in Q1 2026, selling an estimated $72.1K and leaving 960 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

JTC Employer Solutions Trustee first reported a position in TEVA in Q2 2021 and has held it in 13 quarters since. The position peaked at $100K in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

JTC Employer Solutions Trustee held 960 shares of Teva Pharmaceuticals worth $29K as of Q1 2026.
JTC Employer Solutions Trustee sold 2,240 Teva Pharmaceuticals shares in Q1 2026, an estimated $72.1K.
Teva Pharmaceuticals made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q1 2026, its #259 holding.
JTC Employer Solutions Trustee first reported a position in Teva Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
JTC Employer Solutions Trustee's Teva Pharmaceuticals position peaked at $100K in Q4 2025.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.